Comparaison de la carbétocine à l’ocytocine pour un accouchement par césarienne non planifié : revue systématique, méta-analyse et analyse séquentielle des études randomisées contrôlées

Translated title of the contribution: Carbetocin compared with oxytocin in non-elective Cesarean delivery: a systematic review, meta-analysis, and trial sequential analysis of randomized-controlled trials

Desire N. Onwochei, Adetokunbo Owolabi, Preet Mohinder Singh, David T. Monks

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Purpose: Carbetocin has been shown to reduce the requirement for additional uterotonics in women exclusively undergoing elective Cesarean delivery (CD). The aim of this review was to determine whether this effect could also be demonstrated in the setting of non-elective CD. Methods: Medline, Embase, CINAHL, Web of Science and Cochrane databases were searched for randomized-controlled trials (RCTs) in any language comparing carbetocin to oxytocin. Studies with data on women undergoing non-elective CD, where carbetocin was compared with oxytocin, were included. The primary outcome was the need for additional uterotonics. Secondary outcomes included incidence of blood transfusion, estimated blood loss (mL), incidence of postpartum hemorrhage (PPH; > 1000 mL) and mean hemoglobin drop (g·dL−1 Results: Five RCTs were included, with a total of 1,214 patients. The need for additional uterotonics was reduced with carbetocin compared with oxytocin (odds ratio, 0.30; 95% CI, 0.11 to 0.86; I2, 90.60%). Trial sequential analysis (TSA) confirmed that the information size needed to show a significant reduction in the need for additional uterotonics had been exceeded. No significant differences were shown with respect to any of the secondary outcomes, but there was significant heterogeneity between the studies. Conclusions: Carbetocin reduces the need for additional uterotonics in non-elective CD compared with oxytocin. TSA confirmed that this analysis was appropriately powered to detect the pooled estimated effect. Further trials utilizing consistent core outcomes are needed to determine an effect on PPH. Trial registration: PROSPERO CRD42019147256, registered 13 September 2019.

Translated title of the contributionCarbetocin compared with oxytocin in non-elective Cesarean delivery: a systematic review, meta-analysis, and trial sequential analysis of randomized-controlled trials
Original languageFrench
Pages (from-to)1524-1534
Number of pages11
JournalCanadian Journal of Anesthesia
Volume67
Issue number11
DOIs
StatePublished - Nov 1 2020

Keywords

  • Carbetocin
  • non-elective Cesarean
  • oxytocin
  • postpartum hemorrhage
  • trial sequential analysis

Fingerprint

Dive into the research topics of 'Carbetocin compared with oxytocin in non-elective Cesarean delivery: a systematic review, meta-analysis, and trial sequential analysis of randomized-controlled trials'. Together they form a unique fingerprint.

Cite this